Cargando…
Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B
Development of antiviral drug resistance is a continuous concern for viruses with high mutation rates such as influenza. The use of antiviral drugs targeting host proteins required for viral replication is less likely to result in the selection of resistant viruses than treating with direct-acting a...
Autores principales: | Warfield, Kelly L., Schaaf, Kaitlyn R., DeWald, Lisa Evans, Spurgers, Kevin B., Wang, Wei, Stavale, Eric, Mendenhall, Michelle, Shilts, Meghan H., Stockwell, Timothy B., Barnard, Dale L., Ramstedt, Urban, Das, Suman R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522537/ https://www.ncbi.nlm.nih.gov/pubmed/31097731 http://dx.doi.org/10.1038/s41598-019-43030-y |
Ejemplares similares
-
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects
por: Callahan, Michael, et al.
Publicado: (2022) -
In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4
por: Stavale, Eric J., et al.
Publicado: (2015) -
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
por: Warfield, Kelly L., et al.
Publicado: (2015) -
Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses
por: Spurgers, Kevin B., et al.
Publicado: (2008) -
The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice
por: Warfield, Kelly L., et al.
Publicado: (2016)